Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
Lymphoid enhancer-binding factor 1 (LEF1) is a neutrophilic granulopoiesis regulator whose absence is critical in congenital neutropenia. We have shown LEF1 downregulation in the CD34(+) cells of the majority of myelodysplastic syndromes (MDS) patients. LEF1 was the most significant differentially e...
Main Authors: | Pellagatti, A, Marafioti, T, Paterson, J, Malcovati, L, Della Porta, MG, Jädersten, M, Pushkaran, B, George, T, Arber, D, Killick, S, Giagounidis, A, Hellström-Lindberg, E, Cazzola, M, Wainscoat, J, Boultwood, J |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2009
|
פריטים דומים
-
Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
מאת: Pellagatti, A, et al.
יצא לאור: (2009) -
Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
מאת: Pellagatti, A, et al.
יצא לאור: (2010) -
Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
מאת: Pellagatti, A, et al.
יצא לאור: (2011) -
Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome
מאת: Pellagatti, A, et al.
יצא לאור: (2011) -
Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
מאת: Pellagatti, A, et al.
יצא לאור: (2010)